Target intelligence / Profile preview

Inorganic dietary phosphate (Pi)

Target
Pi
Molecular classification
Inorganic ion, Nutrient
01

Overview

Inorganic dietary phosphate refers to the free phosphate ions present in the gastrointestinal lumen derived from food sources. In healthy individuals, phosphate is absorbed via passive and active transport (primarily through NaPi-IIb transporters) to maintain mineral homeostasis (National Institutes of Health, 2023). However, in patients with impaired renal function, such as those with chronic kidney disease (CKD), the kidneys cannot effectively excrete excess phosphate, leading to hyperphosphatemia (StatPearls, 2023). This condition is a major driver of secondary hyperparathyroidism, bone disease, and cardiovascular calcification (Journal of Nephrology, 2018). Therapeutic intervention involves the use of phosphate binders, which are orally administered agents that physically bind to inorganic phosphate in the gut (PubMed, 2019). By forming insoluble complexes, these drugs prevent phosphate absorption into the bloodstream, facilitating its excretion in the feces and helping to manage serum phosphorus levels (Nature Reviews Nephrology, 2011).

Other names
Dietary phosphorusInorganic phosphorusOrthophosphatePhosphate ionPO4(3-)
02

Mechanism of action

Phosphate binders act by ion exchange or chemical precipitation within the gastrointestinal lumen, forming insoluble phosphate complexes that are excreted in the feces, thereby reducing systemic absorption (PubMed, 2019).

03

Biological functions

Bone mineralizationEnergy metabolismCell signalingAcid-base balanceNucleic acid synthesis
04

Disease associations

HyperphosphatemiaChronic kidney diseaseSecondary hyperparathyroidismVascular calcificationMineral and bone disorder
05

Safety considerations

Gastrointestinal distress (nausea, constipation, diarrhea)Vascular calcification (associated with calcium-based binders)Drug-drug interactions due to chelation of co-administered medicationsAccumulation of metal ions such as aluminum or lanthanum
06

Interacting drugs

Sevelamer

6 more in the full profile.

07

Biomarkers

Serum phosphorusFibroblast growth factor 23 (FGF23)Parathyroid hormone (PTH)Urinary phosphate excretion

Beyond the preview

Go deeper on Inorganic dietary phosphate (Pi).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inorganic dietary phosphate (Pi).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call